Xifaxan Side Effects
Generic Name: Rifaximin
Please note - some side effects for Xifaxan may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
|
For the consumer For the professional
|
|
Side Effects of Xifaxan - for the consumer
Xifaxan
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Xifaxan:
Seek medical attention right away if any of these SEVERE side effects occur when using Xifaxan:Constipation; gas; headache; nausea; sensations of needing to empty the bowel; stomach pain; urgent bowel movements; vomiting.
TopSevere allergic reactions (rash; hives; itching; difficulty swallowing or breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; flushing); bloody stools; chest pain; fainting; severe diarrhea.
For the professional
Xifaxan
The safety of Xifaxan™ Tablets 200 mg taken three times a day (TID) was evaluated in 320 patients in two placebo-controlled clinical trials with 95% of patients receiving at least three days of treatment with Xifaxan™ Tablets. All adverse events for Xifaxan™ Tablets 200 mg TID that occurred at a frequency ≥2% in the two placebo-controlled trials combined are provided in Table 2. (These include adverse events that may be attributable to the underlying disease.)
| MedDRA Preferred Term | Number (%) of Patients | |
|---|---|---|
| Xifaxan™ Tablets, 600 mg/day (N = 320) |
Placebo N = 228 |
|
| Flatulence |
36 (11.3%) |
45 (19.7%) |
| Headache |
31 (9.7%) |
21 (9.2%) |
| Abdominal Pain NOS |
23 (7.2%) |
23 (10.1%) |
| Rectal Tenesmus |
23 (7.2%) | 20 (8.8%) |
| Defecation Urgency |
19 (5.9%) |
21 (9.2%) |
| Nausea |
17 (5.3%) |
19 (8.3%) |
| Constipation |
12 (3.8%) |
8 (3.5%) |
| Pyrexia |
10 (3.1%) | 10 (4.4%) |
| Vomiting NOS |
7 (2.2%) |
4 (1.8%) |
The following adverse events, presented by body system, have also been reported in <2% of patients taking Xifaxan™ Tablets in the two placebo-controlled clinical trials where the 200 mg taken three times a day dose was used. The following includes adverse events regardless of causal relationship to drug exposure.
Blood and Lymphatic System Disorders: lymphocytosis, monocytosis, neutropenia
Ear and Labyrinth Disorders: ear pain, motion sickness, tinnitus
Gastrointestinal Disorders: abdominal distension, diarrhea NOS, dry throat, fecal abnormality NOS, gingival disorder NOS, inguinal hernia NOS, dry lips, stomach discomfort
General Disorders and Administration Site Conditions: chest pain, fatigue, malaise, pain NOS, weakness
Infections and Infestations: dysentery NOS, respiratory tract infection NOS, upper respiratory tract infection NOS
Injury and Poisoning: sunburn
Investigations: aspartate aminotransferase increased, blood in stool, blood in urine, weight decreased
Metabolic and Nutritional Disorders: anorexia, dehydration
Musculoskeletal, Connective Tissue, and Bone Disorders: arthralgia, muscle spasms, myalgia, neck pain
Nervous System Disorders: abnormal dreams, dizziness, migraine NOS, syncope, loss of taste
Psychiatric Disorders: insomnia
Renal and Urinary Disorders: choluria, dysuria, hematuria, polyuria, proteinuria, urinary frequency
Respiratory, Thoracic, and Mediastinal Disorders: dyspnea NOS, nasal passage irritation, nasopharyngitis, pharyngitis, pharyngolaryngeal pain, rhinitis NOS, rhinorrhea
Skin and Subcutaneous Tissue Disorders: clamminess, rash NOS, sweating increased
Vascular Disorders: hot flashes NOS
Postmarketing Experience
The following events: hypersensitivity reactions, including allergic dermatitis, rash, angioneurotic edema, urticaria, and pruritus; have been identified during foreign postapproval use of Xifaxan™ Tablets. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency or establish a causal relationship to drug exposure.
TopMore resources:
Xifaxan - Includes detailed dosage instructions.
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.




